A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The aim of this phase II trial was to evaluate the feasibility, efficacy and tolerability of
intensity-modulated radiotherapy combined with S-1 based chemotherapy in patients with
pathologically positive lymph node after completely resected gastric cancer. Furthermore, the
investigators sought to compare the dosimetric differences between the volumetric-modulated
arc therapy (VMAT), Tomotherapy and intensity-modulated radiotherapy (IMRT) techniques in
treatment planning for gastric cancer as adjuvant radiotherapy.